Source link : https://www.newshealth.biz/health-news/ozempic-is-appealing-but-not-cost-effective-for-obesity/
To lose weight, patients with obesity may be more interested in semaglutide products, but the glucagon-like peptide 1 agonists, such as Ozempic injections and Rybelsus tablets, are not yet cost-effective, according to a modeling study that compared the drugs with surgery and endoscopy. Sleeve gastrectomy (SG) for moderate to severe (class II/III) obesity and the […]
Author : News Health
Publish date : 2024-01-18 10:06:33
Copyright for syndicated content belongs to the linked Source.